The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
Recruiting
N/A
Interventional Study
Dry Eye
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 10 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aim to evaluate the efficacy of cord blood eye drops in the healing of the damaged corneal epithelium.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age over 18 years
* oncology and advanced cancer patients who have EGFr mutation and who require treatment with antiEGFr drugs
* signing of informed consent
Exclusion Criteria:
* Patients who are unable to store/administer the CSCO independently, or with the help of care-giv…
Contacts